PROTEOMICS AS TOOLS FOR BIOMARKERS DISCOVERY OF ADULTERATION IN SLAUGHTERING PROCEDURES
نویسندگان
چکیده
منابع مشابه
Proteomics Discovery of Disease Biomarkers
Recent technological developments in proteomics have shown promising initiatives in identifying novel biomarkers of various diseases. Such technologies are capable of investigating multiple samples and generating large amount of data end-points. Examples of two promising proteomics technologies are mass spectrometry, including an instrument based on surface enhanced laser desorption/ionization,...
متن کاملDiscovery of Biomarkers for Osteosarcoma by Proteomics Approaches
Osteosarcomas are the most common malignant bone tumors, and the identification of useful tumor biomarkers and target proteins is required to predict the clinical outcome of patients and therapeutic response as well as to develop novel therapeutic strategies. Global protein expression studies, namely, proteomic studies, can offer important clues to understanding the tumor biology that cannot be...
متن کاملProteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases.
Neurodegenerative diseases are characterized by premature neuronal loss in specific brain regions. During the past decades our knowledge on molecular mechanisms underlying neurodegeneration has increased immensely and resulted in promising drug candidates that might slow down or even stop the neuronal loss. These advances have put a strong focus on the development of diagnostic tools for early ...
متن کاملProteomics: approaches and image analysis tools for drug discovery
Proteomics, the science of proteins is the global study of the expression, interaction and modification of proteins within the body. Since proteins are the intermediaries between genetic instruction and all forms of cell activity, advances in proteomics promise to provide insight into disease and to accelerate systematized discovery of new drugs. Proteomics offers medical reaseach groups a way ...
متن کاملProteomics as a Tool for Biomarker Discovery
Novel technologies are now being advanced for the purpose of identification and validation of new disease biomarkers. A reliable and useful clinical biomarker must a) come from a readily attainable source, such as blood or urine, b) have sufficient sensitivity to correctly identify affected individuals, c) have sufficient specificity to avoid incorrect labeling of unaffected persons, and d) res...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Science Heritage Journal
سال: 2019
ISSN: 2521-0858,2521-0866
DOI: 10.26480/gws.01.2019.11.16